FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

MEDICARE DRUG BENEFIT Previous Volume 353:2735-2739 December 29, 2005 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Interview Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

On January 1, 2006, the Medicare Prescription Drug Improvement and Modernization Act (MMA) will become a fact of life for 42 million Medicare beneficiaries and their physicians. For the past three months, America's older citizens have been barraged with educational and marketing initiatives for various drug plans, though it has been an uphill battle: an October poll indicated that 61 percent did not understand the program "somewhat well" and 54 percent did not intend to sign up for coverage.¹

The task of sorting through the myriad alternatives will fall squarely on patients and their physicians. The federal government has posted . . . [Full Text of this Article]

Source Information

Dr. Kravitz is a professor of internal medicine and director of the Center for Health Services Research in Primary Care, University of California, Davis; Dr. Chang is the director of the Chronic Care Disease Program, California HealthCare Foundation, Oakland, Calif.

Related Letters:

Medicare Drug Benefit
Cooper H. A., Lear A. A., Kravitz R. L., Chang S.
Extract | Full Text | PDF  
N Engl J Med 2006; 354:1960-1961, May 4, 2006. Correspondence

This article has been cited by other articles:

• Cabana, M. D., Abu-Isa, H., Thyne, S. M., Yawn, B. (2007). Specialty Differences in Prescribing Inhaled Corticosteroids for Children. CLIN PEDIATR 46: 698-705 [Abstract]  
• Robinson, J. C. (2006). The Commercial Health Insurance Industry In An Era Of Eroding Employer Coverage. Health Aff (Millwood) 25: 1475-1486 [Abstract] [Full Text]  
• Soumerai, S. B., Pierre-Jacques, M., Zhang, F., Ross-Degnan, D., Adams, A. S., Gurwitz, J., Adler, G., Safran, D. G. (2006). Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit.. Arch Intern Med 166: 1829-1835 [Abstract] [Full Text]  
• Federman, A. D., Alexander, G. C., Shrank, W. H. (2006). A Practical Physicians' Guide to the Medicare Drug Benefit Plan. Mayo Clin Proc. 81: 1217-1221 [Full Text]  
• Cooper, H. A., Lear, A. A., Kravitz, R. L., Chang, S. (2006). Medicare drug benefit.. NEJM 354: 1960-1961 [Full Text]